The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-chloro-2-methoxy-N-(2-phenylbenzo[d]oxazol-5-yl)benzenesulfonamide ID: ALA4548800
PubChem CID: 155548951
Max Phase: Preclinical
Molecular Formula: C20H15ClN2O4S
Molecular Weight: 414.87
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(Cl)cc1S(=O)(=O)Nc1ccc2oc(-c3ccccc3)nc2c1
Standard InChI: InChI=1S/C20H15ClN2O4S/c1-26-18-9-7-14(21)11-19(18)28(24,25)23-15-8-10-17-16(12-15)22-20(27-17)13-5-3-2-4-6-13/h2-12,23H,1H3
Standard InChI Key: GMVIJCNJXXMNBV-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
3.6939 -26.7403 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1066 -27.4502 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.5150 -26.7378 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5249 -26.6330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5238 -27.4525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2318 -27.8615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2301 -26.2241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9387 -26.6294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9435 -27.4480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7235 -27.6964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2009 -27.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7157 -26.3719 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0180 -27.0265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4282 -27.7329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2446 -27.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6499 -27.0178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2327 -26.3102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4177 -26.3181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8158 -27.8605 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4003 -27.8594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6936 -27.4502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9878 -27.8588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9887 -28.6759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7011 -29.0827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4040 -28.6718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2797 -27.4509 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.1137 -29.0769 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1178 -29.8941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 1 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
5 19 1 0
19 2 1 0
2 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
22 26 1 0
25 27 1 0
27 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 414.87Molecular Weight (Monoisotopic): 414.0441AlogP: 4.96#Rotatable Bonds: 5Polar Surface Area: 81.43Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.78CX Basic pKa: 0.75CX LogP: 4.28CX LogD: 3.73Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.50Np Likeness Score: -1.93
References 1. Washburn A, Abdeen S, Ovechkina Y, Ray AM, Stevens M, Chitre S, Sivinski J, Park Y, Johnson J, Hoang QQ, Chapman E, Parish T, Johnson SM.. (2019) Dual-targeting GroEL/ES chaperonin and protein tyrosine phosphatase B (PtpB) inhibitors: A polypharmacology strategy for treating Mycobacterium tuberculosis infections., 29 (13): [PMID:31047750 ] [10.1016/j.bmcl.2019.04.034 ]